Cellect Biotherapeutics Ltd.

Calculating rank

USPTO Granted Patents = 3

% Expired Patents = 66.7

CIPO Patents = 1

EPO Patents = 4

Forward Citations = 0

Loading Chart...

3 inventors (with patents filed for the assignee):

Shai Yarkoni (3 out of 10 patents)

Nadir Askenasy (2 out of 4 patents)

Tal Almog (1 out of 1 patent)

3 patents: Sort by Forward Citations

1. 11578306 - Methods for propagating mesenchymal stem cells (MSC) for use in transplantation (2023-02-14),

2. 9783778 - Devices and methods for selecting apoptosis-signaling resistant cells, and uses thereof (2017-10-10),

3. 9624469 - Regulatory immune cells with enhanced targeted cell death effect (2017-04-18),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

3 Patents

#42 in Kfar Saba

#1,779 in Israel

Kfar Saba, Israel

Cellect Biotherapeutics Ltd.

Forward Citations = 0

3 inventors:

Shai Yarkoni (3 out of 10 patents)

Nadir Askenasy (2 out of 4 patents)

Tal Almog (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cellect Biotherapeutics Ltd.. Retrieved from https://idiyas.com/company/cellect-biotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]